Fortress Biotech, Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2010 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Fortress Biotech, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2010 to Q2 2024.
  • Fortress Biotech, Inc. Common Stock, Shares, Outstanding for the quarter ending June 30, 2024 was 22.6M shares, a 82.8% decline year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 22.6M -109M -82.8% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 19.4M -111M -85.1% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 15.1M +7.73M +105% Dec 31, 2023 10-Q 2024-08-13
Q3 2023 8.94M -99.3M -91.7% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 132M +23.9M +22.2% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 130M +24.1M +22.7% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 7.37M -94.1M -92.7% Dec 31, 2022 10-K 2024-03-28
Q3 2022 108M +9.55M +9.67% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 108M +10.2M +10.5% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 106M +9.06M +9.31% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 101M +6.56M +6.91% Dec 31, 2021 10-K 2023-03-31
Q3 2021 98.7M +4.97M +5.3% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 97.5M +11.4M +13.2% Jun 30, 2021 10-Q 2021-08-16
Q1 2021 97.3M +18.7M +23.8% Mar 31, 2021 10-Q 2021-05-17
Q4 2020 94.9M +20.9M +28.2% Dec 31, 2020 10-K 2022-03-28
Q3 2020 93.7M +23.4M +33.3% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 86.1M +28.3M +48.9% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 78.6M +15.4M +24.5% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 74M +16.2M +28% Dec 31, 2019 10-K/A 2021-04-09
Q3 2019 70.3M +14.2M +25.2% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 57.8M +3.86M +7.15% Jun 30, 2019 10-Q 2019-08-09
Q1 2019 63.1M +10.4M +19.8% Mar 31, 2019 10-Q 2019-05-10
Q4 2018 57.8M +6.85M +13.4% Dec 31, 2018 10-K 2020-03-16
Q3 2018 56.2M +5.6M +11.1% Sep 30, 2018 10-Q 2018-11-09
Q2 2018 54M +3.52M +6.98% Jun 30, 2018 10-Q 2018-08-09
Q1 2018 52.7M +2.37M +4.7% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 51M +2.06M +4.21% Dec 31, 2017 10-K 2019-03-18
Q3 2017 50.6M +1.71M +3.5% Sep 30, 2017 10-Q 2017-11-09
Q2 2017 50.5M +1.79M +3.69% Jun 30, 2017 10-Q 2017-08-09
Q1 2017 50.3M +1.8M +3.72% Mar 31, 2017 10-Q 2017-05-10
Q4 2016 48.9M +1.78M +3.79% Dec 31, 2016 10-K 2018-03-16
Q3 2016 48.9M +1.74M +3.7% Sep 30, 2016 10-Q 2016-11-09
Q2 2016 48.7M +1.83M +3.92% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 48.5M +1.7M +3.63% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 47.1M +653K +1.4% Dec 31, 2015 10-K 2017-03-16
Q3 2015 47.1M +2.82M +6.37% Sep 30, 2015 10-Q 2015-11-09
Q2 2015 46.8M +2.52M +5.69% Jun 30, 2015 10-Q 2015-08-10
Q1 2015 46.8M +2.57M +5.8% Mar 31, 2015 10-Q 2015-05-11
Q4 2014 46.5M +6.84M +17.3% Dec 31, 2014 10-K 2016-03-15
Q3 2014 44.3M +9.06M +25.7% Sep 30, 2014 10-Q 2014-11-06
Q2 2014 44.3M +14.7M +49.7% Jun 30, 2014 10-Q 2014-08-11
Q1 2014 44.3M +18.1M +69.1% Mar 31, 2014 10-Q 2014-05-12
Q4 2013 39.7M +15.3M +62.5% Dec 31, 2013 10-K 2015-03-16
Q3 2013 35.3M -24.3B -99.9% Sep 30, 2013 10-Q 2013-11-01
Q2 2013 29.6M +5.23M +21.5% Jun 30, 2013 10-Q 2013-08-05
Q1 2013 26.2M +7.56M +40.7% Mar 31, 2013 10-Q 2013-05-09
Q4 2012 24.4M +5.8M +31.2% Dec 31, 2012 10-K 2014-03-14
Q3 2012 24.4B +24.4B +346735% Sep 30, 2012 10-Q 2012-11-14
Q2 2012 24.4M Jun 30, 2012 10-Q 2012-08-08
Q1 2012 18.6M Mar 31, 2012 10-Q 2012-05-15
Q4 2011 18.6M +13.8M +288% Dec 31, 2011 10-K 2013-03-18
Q3 2011 7.03M Sep 30, 2011 10-Q 2011-11-14
Q4 2010 4.79M Dec 31, 2010 10-K 2012-03-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.